These results suggested that increased levels of oxidative stress play an active role in enhancing tau-mediated neurodegeneration, possibly through cell cycle activation, underscoring the therapeutic potential of targeting antioxidant pathways and cell cycle mechanisms for the treatment of AD and other human tauopathies [48]. Here, MAPT is linked to tauopathy.